Literature DB >> 11499629

Simultaneous determination of F-beta-alanine and beta-alanine in plasma and urine with dual-column reversed-phase high-performance liquid chromatography.

A B Van Kuilenburg1, A E Stroomer, G J Peters, A H Van Gennip.   

Abstract

F-beta-Alanine and beta-alanine were detected in plasma and urine samples with fluorescence detection of orthophthaldialdehyde derivatives of F-beta-alanine and beta-alanine after separation with dual-column reversed-phase HPLC. The detection limits of F-beta-alanine and beta-alanine in the HPLC system were approximately 0.3 and 0.7 pmol, respectively. The procedure proved to be very reproducible with intra-assay RSDs and inter-assay RSDs being less than 8%. The usefulness of the method was demonstrated by the analysis of the F-beta-alanine and beta-alanine concentrations in plasma and urine samples from tumor patients treated with S-1 (Tegafur, 5-chloro-2,4-dihydroxypyridine and potassium oxonate in a molar ratio of 1:0.4:1).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11499629     DOI: 10.1016/s0378-4347(01)00203-1

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  4 in total

1.  Validation of an isocratic HPLC method to detect 2-fluoro-beta-alanine for the analysis of dihydropyrimidine dehydrogenase activity.

Authors:  Kinta M Serve; Jennifer L Darnell; Jody K Takemoto; Neal M Davies; Margaret E Black
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-05-19       Impact factor: 3.205

2.  New insights in dihydropyrimidine dehydrogenase deficiency: a pivotal role for beta-aminoisobutyric acid?

Authors:  André B P Van Kuilenburg; Alida E M Stroomer; Henk Van Lenthe; Nico G G M Abeling; Albert H Van Gennip
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

3.  5-Fluorouracil cardiotoxicity induced by alpha-fluoro-beta-alanine.

Authors:  Katsuki Muneoka; Yoshio Shirai; Naoyuki Yokoyama; Toshifumi Wakai; Katsuyoshi Hatakeyama
Journal:  Int J Clin Oncol       Date:  2005-12       Impact factor: 3.850

4.  Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil.

Authors:  Y Yamada; T Hamaguchi; M Goto; K Muro; Y Matsumura; Y Shimada; K Shirao; S Nagayama
Journal:  Br J Cancer       Date:  2003-09-01       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.